Global Asthma Epidemiology Market (2018-2026) Report - ResearchAndMarkets.com

June 11, 2018

DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The “Global Asthma Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

The research provides insights into Asthma epidemiology, Asthma diagnosed patients, and Asthma treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Asthma derived from epidemiological analysis, patients diagnosed with Asthma, and patients treated with a drug therapy.

The research study helps executives estimate Asthma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Asthma prevalence, Asthma diagnosis rate, and Asthma treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

Asthma Patient Flow Asthma Prevalence Asthma Diagnosed Patients Asthma Treated Patients

Key Topics Covered

1. Asthma: Disease Definition

2. Global Asthma Patient Flow

2A. Global Asthma Prevalence

2B. Global Asthma Diagnosed Patients

2C. Global Asthma Treated Patients

3. Asthma Patient Flow in the US

3A. Asthma Prevalence in the US

3B. Asthma Diagnosed Patients in the US

3C. Asthma Treated Patients in the US

4. Asthma Patient Flow in Europe

4A. Asthma Prevalence in Europe

4B. Asthma Diagnosed Patients in Europe

4C. Asthma Treated Patients in Europe

5. Asthma Patient Flow in Germany

5A. Asthma Prevalence in Germany

5B. Asthma Diagnosed Patients in Germany

5C. Asthma Treated Patients in Germany

6. Asthma Patient Flow in France

6A. Asthma Prevalence in France

6B. Asthma Diagnosed Patients in France

6C. Asthma Treated Patients in France

7. Asthma Patient Flow in Spain

7A. Asthma Prevalence in Spain

7B. Asthma Diagnosed Patients in Spain

7C. Asthma Treated Patients in Spain

8. Asthma Patient Flow in Italy

8A. Asthma Prevalence in Italy

8B. Asthma Diagnosed Patients in Italy

8C. Asthma Treated Patients in Italy

9. Asthma Patient Flow in UK

9A. Asthma Prevalence in UK

9B. Asthma Diagnosed Patients in UK

9C. Asthma Treated Patients in UK

10. Asthma Patient Flow in Japan

10A. Asthma Prevalence in Japan

10B. Asthma Diagnosed Patients in Japan

10C. Asthma Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/cnbzq4/global_asthma?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180611006219/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Asthma Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/11/2018 04:55 PM/DISC: 06/11/2018 04:55 PM


Update hourly